Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Cash from Financing Activities came in at -$214.0 million in Q2 2026, down 247.59% year-over-year from $145.0 million in Q2 2025, and up 50.58% quarter-over-quarter from -$433.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$214.0 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 247.59% year-over-year to -$214.0 million; the TTM figure through Jun 2026 stood at -$684.0 million (down 9.44% YoY), while the FY2025 annual figure was -$150.0 million, up 82.92% from the prior year.
- Cash from Financing Activities came in at -$214.0 million for Q2 2026 at Iqvia Holdings, up from -$433.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $535.0 million in Q4 2025 to a low of -$572.0 million in Q3 2025.
- Average Cash from Financing Activities over 5 years is -$132.6 million, with a median of -$168.5 million recorded in 2022.
- Year-over-year, Cash from Financing Activities surged 427.59% in 2023 and plunged 373.68% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$193.0 million in 2022, then sank by 117.62% to -$420.0 million in 2023, then grew by 10.71% to -$375.0 million in 2024, then jumped by 242.67% to $535.0 million in 2025, then tumbled by 140.0% to -$214.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$214.0 million in Q2 2026, -$433.0 million in Q1 2026, and $535.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -214.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -288.34 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -8.12 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -164.66 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 16.49 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 33,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 248,151.59 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -118,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -214.00 Mn |
| Mar 31, 2026 | -433.00 Mn |
| Dec 31, 2025 | 535.00 Mn |
| Sep 30, 2025 | -572.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Mar 31, 2025 | -258.00 Mn |
| Dec 31, 2024 | -375.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Mar 31, 2024 | -106.00 Mn |
| Dec 31, 2023 | -420.00 Mn |
| Sep 30, 2023 | -144.00 Mn |
| Jun 30, 2023 | 95.00 Mn |
| Mar 31, 2023 | 87.00 Mn |
| Dec 31, 2022 | -193.00 Mn |
| Sep 30, 2022 | -251.00 Mn |
| Jun 30, 2022 | -29.00 Mn |
| Mar 31, 2022 | 144.00 Mn |
| Dec 31, 2021 | -138.00 Mn |
| Sep 30, 2021 | -66.00 Mn |